6wpt
From Proteopedia
(Difference between revisions)
m (Protected "6wpt" [edit=sysop:move=sysop]) |
|||
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)== | |
| + | <StructureSection load='6wpt' size='340' side='right'caption='[[6wpt]], [[Resolution|resolution]] 3.70Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WPT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6WPT FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.7Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6wpt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wpt OCA], [https://pdbe.org/6wpt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6wpt RCSB], [https://www.ebi.ac.uk/pdbsum/6wpt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6wpt ProSAT]</span></td></tr> | ||
| + | </table> | ||
| - | + | ==See Also== | |
| - | + | *[[Antibody 3D structures|Antibody 3D structures]] | |
| - | + | *[[3D structures of human antibody|3D structures of human antibody]] | |
| - | [[Category: | + | __TOC__ |
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Beltramello M]] | ||
| + | [[Category: Bianchi S]] | ||
| + | [[Category: Cameroni E]] | ||
| + | [[Category: Case JB]] | ||
| + | [[Category: Chen RE]] | ||
| + | [[Category: Corti D]] | ||
| + | [[Category: Culap K]] | ||
| + | [[Category: De Marco A]] | ||
| + | [[Category: Diamond MS]] | ||
| + | [[Category: Fink K]] | ||
| + | [[Category: Guarino B]] | ||
| + | [[Category: Havenar-Daughton C]] | ||
| + | [[Category: Jaconi S]] | ||
| + | [[Category: Lanzavecchia A]] | ||
| + | [[Category: Park YJ]] | ||
| + | [[Category: Peter A]] | ||
| + | [[Category: Pinto D]] | ||
| + | [[Category: Snell G]] | ||
| + | [[Category: Spreafico R]] | ||
| + | [[Category: Tortorici MA]] | ||
| + | [[Category: Veesler D]] | ||
| + | [[Category: Virgin HW]] | ||
| + | [[Category: Walls AC]] | ||
| + | [[Category: Zatta F]] | ||
Current revision
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
| |||||||||||
Categories: Large Structures | Beltramello M | Bianchi S | Cameroni E | Case JB | Chen RE | Corti D | Culap K | De Marco A | Diamond MS | Fink K | Guarino B | Havenar-Daughton C | Jaconi S | Lanzavecchia A | Park YJ | Peter A | Pinto D | Snell G | Spreafico R | Tortorici MA | Veesler D | Virgin HW | Walls AC | Zatta F
